Latest News of PHAR
Alliance Pharma PLC (FRA:DVL) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue ...
By Yahoo! Finance |
4 hours ago
The company is focusing on expanding MacuShield and Hydromol brands in new markets by building clinician awareness gradually. Priorities include addressing issues like the buy box problem for Amberen ...
Criminals set up fake online pharmacies to sell deadly counterfeit pills, prosecutors say
By AP NEWS |
14 hours ago
A drug trafficking network sold dangerous synthetic opioids disguised as prescription drugs through fake online pharmacies, resulting in at least nine deaths. The leader orchestrated the scheme from t...
Invesco EQV European Equity Fund Bolsters Position in Teva Pharmaceutical with a 1. ...
By Yahoo! Finance |
18 hours ago
Invesco EQV European Equity Fund has disclosed its recent investments, adding new stocks like Teva Pharmaceutical and increasing stakes in others such as BAE Systems. The fund also reduced positions i...
-
LEO Pharma announces Enstilar NDA submission for plaque psoriasis in China
By Yahoo! Finance | 1 day agoLEO Pharma has submitted an NDA in China for Enstilar, a new treatment for plaque psoriasis. Enstilar aims to improve upon the existing standard treatment, Daivobet ointment....
-
Could Amazon Pharmacy Become the Largest Drug Store in the USA?
By Forbes | 1 day agoAmazon has quietly entered the healthcare market, particularly in prescription drugs. With the launch of Amazon Pharmacy, offering discounts and convenience, it aims to revolutionize the sector. The c...
-
Verrica Pharmaceuticals Inc. (VRCA): Worst 52-Week Low Stock to Buy Now
By Yahoo! Finance | 1 day agoThe recent interest rate cut by the U.S. Federal Reserve has boosted investor sentiment and market outlook. With stocks rallying, the focus shifts to stocks at 52-week lows, presenting potential buyin...
-
Benitec Biopharma (NASDAQ:BNTC) Is In A Good Position To Deliver On Growth Plans
By Yahoo! Finance | 2 days agoBenitec Biopharma's stock has surged 205%, despite being a loss-making company. Analyzing its cash burn rate and runway, it seems relatively promising. However, potential dilution and risks should be ...
-
Jim Cramer on Regeneron Pharmaceuticals Inc. (REGN): 'Leerink Analysts Downgraded Regeneron To A Market Perform Hold After A Negative Eylea 2mg Biosimilar Preliminary Injunction Ruling'
By Yahoo! Finance | 3 days agoThe article discusses Jim Cramer's investing experiences and emphasizes the importance of starting early in the stock market. It also highlights Regeneron Pharmaceuticals Inc. as a strong investment o...
-
Paris Fashion Week: Pharrell, Daniel Craig, Cardi B, And Pat Cleveland
By Forbes | 3 days agoParis Fashion Week is a spectacle of couples, captured by renowned photographers like Jacopo Raule and Stephane Cardinale. From Daniel Craig to Cardi B, each duo tells a unique story through their fas...
-
Breakeven Is Near for Botanix Pharmaceuticals Limited (ASX:BOT)
By Yahoo! Finance | 3 days agoBotanix Pharmaceuticals Limited is analyzed for potential profitability, with analysts predicting breakeven in 2025. Despite high growth expectations and irregular cash flows typical in the pharmaceut...
-
Burglars hit 4 San Fernando Valley pharmacies
By CBS News | 3 days agoMultiple pharmacies in western San Fernando Valley were targeted by thieves in the early hours of Friday morning. Security footage captured suspects in black hoodies and masks stealing narcotics and c...
-
The past year for Cyclopharm (ASX:CYC) investors has not been profitable
By Yahoo! Finance | 3 days agoInvestors can benefit from a rising market by buying an index fund. Active investors aim to outperform the market but risk under-performance. Cyclopharm Limited (ASX:CYC) shareholders faced a 48% shar...
-
Stocks to Watch: Wynn Resorts, Estrella Immunopharma, Amazon.com
By MarketWatch | 3 days agoWynn Resorts' stock rose as Morgan Stanley upgraded its recommendation following China's stimulus announcement. Analysts believe the company's investments and strong brand in Macau will drive growth. ...
-
Regeneron Pharmaceuticals Suffers Worst Month in Two Years After Legal Setback
By Yahoo! Finance | 3 days agoRegeneron Pharmaceuticals Inc. faces a major setback as a court ruling paves the way for Amgen Inc. to launch a competing therapy to Eylea. Regeneron's stock dropped 12% in September but rose slightly...
-
Q4 2024 Aytu Biopharma Inc Earnings Call
By Yahoo! Finance | 3 days agoJoshua Disbrow, CEO of Aytu Biopharma, discusses the fiscal 2024 Q4 earnings call with positive results. Focus on Rx business growth, pediatric portfolio improvement, and leveraging RxConnect for futu...